Guidelines on the Prevention and Control of Tuberculosis in Ireland
Guidelines on the Prevention and Control of Tuberculosis in Ireland
Guidelines on the Prevention and Control of Tuberculosis in Ireland
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<str<strong>on</strong>g>Guidel<strong>in</strong>es</str<strong>on</strong>g> <strong>on</strong> <strong>the</strong> Preventi<strong>on</strong> <strong>and</strong> C<strong>on</strong>trol <strong>of</strong> <strong>Tuberculosis</strong> <strong>in</strong> Irel<strong>and</strong> 2010HSE/HPSCRecommendati<strong>on</strong>:Prior to commenc<strong>in</strong>g TNF-α antag<strong>on</strong>ists, patients should be thoroughly assessed by <strong>the</strong>treat<strong>in</strong>g physician for cl<strong>in</strong>ically active TB disease <strong>and</strong> for LTBI.Figure 3.2: Algorithm for TB assessment prior to <strong>the</strong> use <strong>of</strong> TNF-α antag<strong>on</strong>istsCheck for cl<strong>in</strong>ically active TB diseaseInclude cl<strong>in</strong>ical history, physical exam <strong>and</strong> chestradiographPOSITIVECurative treatmentNEGATIVECheck for LTBI2 TU Mantoux (>5mm may be a more usefulcut-<strong>of</strong>f if immunosupressed)POSITIVETreatmentAt least 9 m<strong>on</strong>thsis<strong>on</strong>iazid or 4 m<strong>on</strong>thsrifampic<strong>in</strong> +/- is<strong>on</strong>iazid.Pyridox<strong>in</strong>e may beadded.NEGATIVETreat with TNF-α antag<strong>on</strong>istsMa<strong>in</strong>ta<strong>in</strong> a high <strong>in</strong>dex <strong>of</strong> cl<strong>in</strong>ical suspici<strong>on</strong> fordevelopment <strong>of</strong> TBRisk assessmentC<strong>on</strong>sider <strong>in</strong>itiati<strong>on</strong> <strong>of</strong> TNF-α antag<strong>on</strong>ists afterTB treatment commenced, if possiblepostp<strong>on</strong>e until LTBI treatment is complete-43-